These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 35660333)

  • 1. Health care provider decision-making around prenatal substance use reporting.
    Roberts SC; Zaugg C; Martinez N
    Drug Alcohol Depend; 2022 Aug; 237():109514. PubMed ID: 35660333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health care provider reporting practices related to self-managed abortion.
    Roberts SCM; Zaugg C; Grossman D
    BMC Womens Health; 2023 Mar; 23(1):136. PubMed ID: 36973776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obstetric and Pediatric Provider Perspectives on Mandatory Reporting of Prenatal Substance Use.
    Jarlenski M; Minney S; Hogan C; Chang JC
    J Addict Med; 2019; 13(4):258-263. PubMed ID: 30550393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perceptions of child protective services among pregnant or recently pregnant, opioid-using women in substance abuse treatment.
    Falletta L; Hamilton K; Fischbein R; Aultman J; Kinney B; Kenne D
    Child Abuse Negl; 2018 May; 79():125-135. PubMed ID: 29433069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of U.S. State Laws Requiring Health Care Provider Reporting of Perinatal Substance Use.
    Jarlenski M; Hogan C; Bogen DL; Chang JC; Bodnar LM; Van Nostrand E
    Womens Health Issues; 2017; 27(3):264-270. PubMed ID: 28129942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of knowledge on attitudes of emergency department staff towards patients with substance related presentations: a quantitative systematic review protocol.
    Clarke DE; Gonzalez M; Pereira A; Boyce-Gaudreau K; Waldman C; Demczuk L
    JBI Database System Rev Implement Rep; 2015 Oct; 13(10):133-45. PubMed ID: 26571289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Someone who is in this thing that I am suffering from": The role of peers and other facilitators for task sharing substance use treatment in South African HIV care.
    Magidson JF; Joska JA; Regenauer KS; Satinsky E; Andersen LS; Seitz-Brown CJ; Borba CPC; Safren SA; Myers B
    Int J Drug Policy; 2019 Aug; 70():61-69. PubMed ID: 31082664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What factors influence health professionals to use decision aids for Down syndrome prenatal screening?
    Lépine J; Leiva Portocarrero ME; Delanoë A; Robitaille H; Lévesque I; Rousseau F; Wilson BJ; Giguère AM; Légaré F
    BMC Pregnancy Childbirth; 2016 Sep; 16(1):262. PubMed ID: 27596573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between U.S. state prenatal drug use laws and child welfare reporting in Alabama, Maryland and Utah.
    Bandara S; Schall TE; White SA; McCourt AD; Goodman D; McGinty EE
    Int J Drug Policy; 2022 Oct; 108():103806. PubMed ID: 35907372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients' characteristics and providers' attitudes: predictors of screening pregnant women for illicit substance use.
    Kerker BD; Horwitz SM; Leventhal JM
    Child Abuse Negl; 2004 Feb; 28(2):209-23. PubMed ID: 15003403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pregnant people's experiences discussing their cannabis use with prenatal care providers in a state with legalized cannabis.
    Woodruff K; Scott KA; Roberts SCM
    Drug Alcohol Depend; 2021 Oct; 227():108998. PubMed ID: 34482037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Right care, first time: a highly personalised and measurement-based care model to manage youth mental health.
    Hickie IB; Scott EM; Cross SP; Iorfino F; Davenport TA; Guastella AJ; Naismith SL; Carpenter JS; Rohleder C; Crouse JJ; Hermens DF; Koethe D; Markus Leweke F; Tickell AM; Sawrikar V; Scott J
    Med J Aust; 2019 Nov; 211 Suppl 9():S3-S46. PubMed ID: 31679171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "The elephant in the room;" a qualitative study of perinatal fears in opioid use disorder treatment in Southern Appalachia.
    Leiner C; Cody T; Mullins N; Ramage M; Ostrach BMM
    BMC Pregnancy Childbirth; 2021 Feb; 21(1):143. PubMed ID: 33596843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring how to enhance care and pathways between the emergency department and integrated youth services for young people with mental health and substance use concerns.
    Glowacki K; Whyte M; Weinstein J; Marchand K; Barbic D; Scheuermeyer F; Mathias S; Barbic S
    BMC Health Serv Res; 2022 May; 22(1):615. PubMed ID: 35525965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shaping legal abortion provision in Ghana: using policy theory to understand provider-related obstacles to policy implementation.
    Aniteye P; Mayhew SH
    Health Res Policy Syst; 2013 Jul; 11():23. PubMed ID: 23829555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mobile technologies to support healthcare provider to healthcare provider communication and management of care.
    Gonçalves-Bradley DC; J Maria AR; Ricci-Cabello I; Villanueva G; Fønhus MS; Glenton C; Lewin S; Henschke N; Buckley BS; Mehl GL; Tamrat T; Shepperd S
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD012927. PubMed ID: 32813281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Government and Non-Government Alcohol and Other Drug (AOD) Treatment Service Delivery for the Lesbian, Gay, Bisexual, and Transgender (LGBT) Community.
    Mullens AB; Fischer J; Stewart M; Kenny K; Garvey S; Debattista J
    Subst Use Misuse; 2017 Jul; 52(8):1027-1038. PubMed ID: 28318357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity in prenatal substance use screening despite universal screening recommendations: findings from the Pregnancy Risk Assessment Monitoring System, 2016-2018.
    Patel E; Bandara S; Saloner B; Stuart EA; Goodman D; Terplan M; McCourt A; White S; McGinty EE
    Am J Obstet Gynecol MFM; 2021 Sep; 3(5):100419. PubMed ID: 34116233
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.